Figure 6
Figure 6. CCR5 down-regulation in EGFP-expressing human monocyte/macrophage population in multiple lymphoid organs. (A) Normalized mean CCR5 expression was compared in EGFP+ and mCherry+ human CD14+/CD33+ monocyte/macrophage population in multiple tissues. Bar represents mean value. Samples were analyzed between 14 and 20 weeks after intravenous CD34+ cell injection. Aggregate difference, comparing CCR5 expression in EGFP+ versus mCherry+ cells in all tissues, was statistically significant by Student t test (P < .001). (B) Gating strategies are the same as shown in Figure 5B except for the use of CD14 and CD33 markers. (C) Representative data showing CCR5 expression in CD14+/CD33+ monocyte/macrophage population.

CCR5 down-regulation in EGFP-expressing human monocyte/macrophage population in multiple lymphoid organs. (A) Normalized mean CCR5 expression was compared in EGFP+ and mCherry+ human CD14+/CD33+ monocyte/macrophage population in multiple tissues. Bar represents mean value. Samples were analyzed between 14 and 20 weeks after intravenous CD34+ cell injection. Aggregate difference, comparing CCR5 expression in EGFP+ versus mCherry+ cells in all tissues, was statistically significant by Student t test (P < .001). (B) Gating strategies are the same as shown in Figure 5B except for the use of CD14 and CD33 markers. (C) Representative data showing CCR5 expression in CD14+/CD33+ monocyte/macrophage population.

Close Modal

or Create an Account

Close Modal
Close Modal